This study provides Class III evidence that IFNβ-1b is associated with a reduction in MRI PBH formation and evolution compared with GA between years 1 and 2 of treatment.
Matilde Inglese, J.H.T.M. van Waesberghe, Marco Rovaris, K. Beckmann, Frederik Barkhof, David W. Hahn, Ludwig Kappos, David H. Miller, C. Polman, Carlo Pozzilli, Alan J. Thompson, Tarek Yousry, Klaus Wagner, Giancarlo Comi, Massimo Filippi
Marco Rovaris, Giancarlo Comi, Maria A. Rocca, Paola Valsasina, David Ladkani, E Pieri, S. Weiss, Galia Shifroni, J. S. Wolinsky, Massimo Filippi, European Canadian Glatiramer Acetate Study Group
Hans-Peter Hartung, Ludwig Kappos, Douglas S. Goodin, Paul O’Connor, Massimo Filippi, Barry G.W. Arnason, Giancarlo Comi, Stuart D. Cook, Douglas Jeffery, John Petkau, Richard White, Timon Bogumil, K. Beckmann, Brigitte Stemper, Gustavo Cruz, Rupert Sandbrink, Christoph Pohl
P. D. Molyneux, Ludwig Kappos, Chris H. Polman, Carlo Pozzilli, Frederik Barkhof, Massimo Filippi, Tarek Yousry, David W. Hahn, Klaus Wagner, Mahdiyeh Khabbaz Koche Ghazi, K. Beckmann, Frank Dahlke, Nicholas Losseff, Gareth J. Barker, Alan J. Thompson, D. H. Miller
Discussion(0)
No comments yet. Be the first to comment.